naloxone hydrochloride
Generic: naloxone hydrochloride
Labeler: baxter healthcare corporationDrug Facts
Product Profile
Brand Name
naloxone hydrochloride
Generic Name
naloxone hydrochloride
Labeler
baxter healthcare corporation
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
naloxone hydrochloride .4 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
36000-308
Product ID
36000-308_ad8223dd-206d-4fd8-b0fb-de10e970a9e1
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214785
Listing Expiration
2027-12-31
Marketing Start
2021-01-29
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
36000308
Hyphenated Format
36000-308
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naloxone hydrochloride (source: ndc)
Generic Name
naloxone hydrochloride (source: ndc)
Application Number
ANDA214785 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .4 mg/mL
Packaging
- 10 VIAL, SINGLE-DOSE in 1 CARTON (36000-308-10) / 1 mL in 1 VIAL, SINGLE-DOSE (36000-308-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "ad8223dd-206d-4fd8-b0fb-de10e970a9e1", "openfda": {"upc": ["0336000308014"], "unii": ["F850569PQR"], "rxcui": ["1659929"], "spl_set_id": ["d04ae2d7-01b9-405d-bb7a-bf2d876ce26a"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (36000-308-10) / 1 mL in 1 VIAL, SINGLE-DOSE (36000-308-01)", "package_ndc": "36000-308-10", "marketing_start_date": "20210129"}], "brand_name": "naloxone hydrochloride", "product_id": "36000-308_ad8223dd-206d-4fd8-b0fb-de10e970a9e1", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "36000-308", "generic_name": "naloxone hydrochloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "naloxone hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA214785", "marketing_category": "ANDA", "marketing_start_date": "20210129", "listing_expiration_date": "20271231"}